These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23770450)

  • 1. Synthesis of N-substituted acyclic β-amino acids and their investigation as GABA uptake inhibitors.
    Sitka I; Allmendinger L; Fülep G; Höfner G; Wanner KT
    Eur J Med Chem; 2013 Jul; 65():487-99. PubMed ID: 23770450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and SAR studies of GABA uptake inhibitors derived from 2-substituted pyrrolidine-2-yl-acetic acids.
    Steffan T; Renukappa-Gutke T; Höfner G; Wanner KT
    Bioorg Med Chem; 2015 Mar; 23(6):1284-306. PubMed ID: 25698617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 4-hydroxy-4-(4-methoxyphenyl)-substituted proline and pyrrolidin-2-ylacetic acid derivatives as GABA uptake inhibitors.
    Zhao X; Pabel J; Höfner GC; Wanner KT
    Bioorg Med Chem; 2013 Jan; 21(2):470-84. PubMed ID: 23245753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Non-GAT1-Selective Inhibitors: Challenges and Achievements.
    Damgaard M; Haugaard AS; Kickinger S; Al-Khawaja A; Lie MEK; Ecker GF; Clausen RP; Frølund B
    Adv Neurobiol; 2017; 16():315-332. PubMed ID: 28828618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereospecific synthesis and structure-activity relationships of unsymmetrical 4,4-diphenylbut-3-enyl derivatives of nipecotic acid as GAT-1 inhibitors.
    Pizzi DA; Leslie CP; Di Fabio R; Seri C; Bernasconi G; Squaglia M; Carnevale G; Falchi A; Greco E; Mangiarini L; Negri M
    Bioorg Med Chem Lett; 2011 Jan; 21(1):602-5. PubMed ID: 21134748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibitors of GABA uptake: synthesis and molecular pharmacology of 4-N-methylamino-4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol analogues.
    Clausen RP; Moltzen EK; Perregaard J; Lenz SM; Sanchez C; Falch E; Frølund B; Bolvig T; Sarup A; Larsson OM; Schousboe A; Krogsgaard-Larsen P
    Bioorg Med Chem; 2005 Feb; 13(3):895-908. PubMed ID: 15653355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Binding Modes of Small and Large Binders of GAT1.
    Wein T; Petrera M; Allmendinger L; Höfner G; Pabel J; Wanner KT
    ChemMedChem; 2016 Mar; 11(5):509-18. PubMed ID: 26804464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors.
    Quandt G; Höfner G; Wanner KT
    Bioorg Med Chem; 2013 Jun; 21(11):3363-78. PubMed ID: 23598250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an (S)-1-{2-[tris(4-methoxyphenyl)methoxy]ethyl}piperidine-3-carboxylic acid [(S)-SNAP-5114] carba analogue inhibitor for murine γ-aminobutyric acid transporter type 4.
    Pabel J; Faust M; Prehn C; Wörlein B; Allmendinger L; Höfner G; Wanner KT
    ChemMedChem; 2012 Jul; 7(7):1245-55. PubMed ID: 22544452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological identification of a guanidine-containing β-alanine analogue with low micromolar potency and selectivity for the betaine/GABA transporter 1 (BGT1).
    Al-Khawaja A; Petersen JG; Damgaard M; Jensen MH; Vogensen SB; Lie ME; Kragholm B; Bräuner-Osborne H; Clausen RP; Frølund B; Wellendorph P
    Neurochem Res; 2014 Oct; 39(10):1988-96. PubMed ID: 24852577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of specific antibodies against GABA transporter subtypes (GAT1, GAT2, GAT3) and their application to immunocytochemistry.
    Ikegaki N; Saito N; Hashima M; Tanaka C
    Brain Res Mol Brain Res; 1994 Oct; 26(1-2):47-54. PubMed ID: 7854065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible role of the non-GAT1 GABA transporters in transfer of GABA from GABAergic to glutamatergic neurons in mouse cerebellar neuronal cultures.
    Suñol C; Babot Z; Cristòfol R; Sonnewald U; Waagepetersen HS; Schousboe A
    Neurochem Res; 2010 Sep; 35(9):1384-90. PubMed ID: 20512624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel selective gamma-aminobutyric acid transport inhibitor demonstrates a functional role for GABA transporter subtype GAT2/BGT-1 in the CNS.
    Clausen RP; Frølund B; Larsson OM; Schousboe A; Krogsgaard-Larsen P; White HS
    Neurochem Int; 2006; 48(6-7):637-42. PubMed ID: 16517017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of sialic acid in the regulation of γ--aminobutyric acid uptake activity of γ-aminobutyric acid transporter 1.
    Hu J; Fei J; Reutter W; Fan H
    Glycobiology; 2011 Mar; 21(3):329-39. PubMed ID: 21045010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotaurine Is a Substrate of GABA Transporter Family Members GAT2/Slc6a13 and TAUT/Slc6a6.
    Nishimura T; Higuchi K; Yoshida Y; Sugita-Fujisawa Y; Kojima K; Sugimoto M; Santo M; Tomi M; Nakashima E
    Biol Pharm Bull; 2018; 41(10):1523-1529. PubMed ID: 30270321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a subtype selective inhibitor of the human betaine/GABA transporter 1 (BGT-1) with a non-competitive pharmacological profile.
    Kragholm B; Kvist T; Madsen KK; Jørgensen L; Vogensen SB; Schousboe A; Clausen RP; Jensen AA; Bräuner-Osborne H
    Biochem Pharmacol; 2013 Aug; 86(4):521-8. PubMed ID: 23792119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs.
    White HS; Sarup A; Bolvig T; Kristensen AS; Petersen G; Nelson N; Pickering DS; Larsson OM; Frølund B; Krogsgaard-Larsen P; Schousboe A
    J Pharmacol Exp Ther; 2002 Aug; 302(2):636-44. PubMed ID: 12130726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an LC-ESI-MS/MS quantification method for a potential γ-aminobutyric acid transporter 3 (GAT3) marker and its application in preliminary MS binding assays.
    Polley M; Höfner G; Wanner KT
    Biomed Chromatogr; 2013 May; 27(5):641-54. PubMed ID: 23225341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with an alkyne spacer as GABA uptake inhibitors.
    Tóth K; Höfner G; Wanner KT
    Bioorg Med Chem; 2018 Jul; 26(12):3668-3687. PubMed ID: 29886082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABA transporters as drug targets for modulation of GABAergic activity.
    Schousboe A; Sarup A; Larsson OM; White HS
    Biochem Pharmacol; 2004 Oct; 68(8):1557-63. PubMed ID: 15451399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.